Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul-Sep;10(3):249-253.
doi: 10.4103/UA.UA_106_17.

Characterization and outcomes of local treatment for primary bladder lymphoma: A population-based cohort analysis

Affiliations

Characterization and outcomes of local treatment for primary bladder lymphoma: A population-based cohort analysis

David P Sellman et al. Urol Ann. 2018 Jul-Sep.

Abstract

Introduction: Primary bladder lymphoma (PBL) is rare, representing 0.2% of extranodal lymphoma and less than 1% of all tumors originating in the bladder. Since the initial description of the disease, low-grade mucosa-associated lymphoid tissue (MALT) lymphoma has been reported as the most common subtype while high-grade disease was thought to represent only 20% of the reported cases.

Materials and methods: One hundred and ninety five patients with PBL from the Surveillance, Epidemiology, and End Results (SEER) registry from 1998-2010 were reviewed. Tumors were classified as high or low grade based on histologic subtype of lymphoma based on revised European-American Lymphoma classification system. Socio-demographic and clinical variables were reported, as well as survival outcome analyses using the Kaplan-Meier method and log-rank test. Cox proportional hazard analysis was used to generate hazard ratios for risk factors associated with mortality.

Results: Eighty-three patients (42.6%) with low-grade and 112 patients (57.4%) with high-grade bladder lymphoma were studied. There were no differences between the low and high-grade groups for socio-demographic or clinical variables. Median overall survival or patients with low-grade disease was 38 months versus 15 months for patients with high-grade disease (p< 0.001). Analysis demonstrated worse survival outcomes for patients with high-grade disease compared to low-grade disease (p< 0.001). On multivariable analysis, increasing age and high-grade disease were associated with worse disease specific mortality (p< 0.001).

Conclusion: Patient with high-grade primary bladder lymphoma had worse survival outcomes compared to those with low-grade disease. While transurethral resection provides tissue for diagnosis, immunotherapy/chemotherapy remains the mainstay of treatment for bladder lymphoma. Consolidation chemotherapy has been recommended in young patients not achieving complete remission with immunotherapy/chemotherapy.

Keywords: Bladder cancer; SEER; lymphoma; outcomes.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Kaplan-Meier analysis for disease specific survival (p<0.0001)
Figure 2
Figure 2
Kaplan-Meier analysis for overall survival (p<0.0001)

References

    1. Evans DA, Moore AT. The first case of vesico-vaginal fistula in a patient with primary lymphoma of the bladder – A case report. J Med Case Rep. 2007;1:105. - PMC - PubMed
    1. Maninderpal KG, Amir FH, Azad HA, Mun KS. Imaging findings of a primary bladder maltoma. Br J Radiol. 2011;84:e186–90. - PMC - PubMed
    1. Kempton CL, Kurtin PJ, Inwards DJ, Wollan P, Bostwick DG. Malignant lymphoma of the bladder: Evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol. 1997;21:1324–33. - PubMed
    1. Mourad WA, Khalil S, Radwi A, Peracha A, Ezzat A. Primary T-cell lymphoma of the urinary bladder. Am J Surg Pathol. 1998;22:373–7. - PubMed
    1. Hughes M, Morrison A, Jackson R. Primary bladder lymphoma: Management and outcome of 12 patients with a review of the literature. Leuk Lymphoma. 2005;46:873–7. - PubMed